{"transactions":[{"id":734032,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-17T20:41:40.000Z","date":"2026-06-16","kind":"sale","planned":true,"acquired":false,"shares":21571,"price":3.73,"value":80459.83,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.66 to $3.78, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":250749,"source":{"system":"sec-edgar","filing":"0001193125-26-274275","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000119312526274275/ownership.xml","form_type":"4"}},{"id":734031,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-17T20:41:40.000Z","date":"2026-06-16","kind":"grant","planned":true,"acquired":true,"shares":63481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":272320,"source":{"system":"sec-edgar","filing":"0001193125-26-274275","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000119312526274275/ownership.xml","form_type":"4"}},{"id":774959,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T20:37:27.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":4137,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30099,"source":{"system":"sec-edgar","filing":"0002064832-26-000211","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000206483226000211/form4.xml","form_type":"4"}},{"id":1113292,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-06-12T20:26:42.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":208839,"source":{"system":"sec-edgar","filing":"0000950170-25-085438","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000095017025085438/ownership.xml","form_type":"4"}},{"id":1114863,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-11T20:33:01.000Z","date":"2025-06-09","kind":"sale","planned":true,"acquired":false,"shares":5192,"price":81.62,"value":423771.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2025."}],"balance_after":25962,"source":{"system":"sec-edgar","filing":"0001062993-25-011413","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000106299325011413/form4.xml","form_type":"4"}},{"id":1145294,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-16T20:40:54.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":4543,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4543,"derivative":{"exercise_price":78.81,"exercise_date":"2026-05-14","expiration_date":"2035-05-14","underlying":"Common Stock","underlying_shares":4543},"source":{"system":"sec-edgar","filing":"0001062993-25-009697","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000106299325009697/form4.xml","form_type":"4"}},{"id":1145293,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-16T20:40:54.000Z","date":"2025-05-14","kind":"grant","planned":false,"acquired":true,"shares":2537,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":31154,"source":{"system":"sec-edgar","filing":"0001062993-25-009697","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000106299325009697/form4.xml","form_type":"4"}},{"id":1471995,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-06-21T20:05:08.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":24311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":163839,"source":{"system":"sec-edgar","filing":"0000950170-24-076210","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000095017024076210/ownership.xml","form_type":"4"}},{"id":1482023,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-06-12T20:05:03.000Z","date":"2024-06-10","kind":"sale","planned":true,"acquired":false,"shares":22766,"price":6.29,"value":143198.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.95 to $6.55, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":139528,"source":{"system":"sec-edgar","filing":"0000950170-24-072417","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000095017024072417/ownership.xml","form_type":"4"}},{"id":1497807,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-30T20:32:52.000Z","date":"2024-05-28","kind":"sale","planned":true,"acquired":false,"shares":2500,"price":78.5,"value":196250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2024."}],"balance_after":28617,"source":{"system":"sec-edgar","filing":"0000950170-24-066683","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000095017024066683/ownership.xml","form_type":"4"}},{"id":1519045,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-13T21:03:58.000Z","date":"2024-05-09","kind":"grant","planned":false,"acquired":true,"shares":4853,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4853,"derivative":{"exercise_price":75.9,"exercise_date":"2025-05-09","expiration_date":"2034-05-09","underlying":"Common Stock","underlying_shares":4853},"source":{"system":"sec-edgar","filing":"0000950170-24-058814","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000095017024058814/ownership.xml","form_type":"4"}},{"id":1519044,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-13T21:03:58.000Z","date":"2024-05-09","kind":"grant","planned":false,"acquired":true,"shares":2635,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":31117,"source":{"system":"sec-edgar","filing":"0000950170-24-058814","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000095017024058814/ownership.xml","form_type":"4"}},{"id":1846469,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-06-22T21:29:51.000Z","date":"2023-06-20","kind":"grant","planned":false,"acquired":true,"shares":22350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2023, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":162294,"source":{"system":"sec-edgar","filing":"0001209191-23-039139","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919123039139/doc4.xml","form_type":"4"}},{"id":1858837,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-12T16:06:04.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of June 8, 2024, and the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of the grant."}],"balance_after":20000,"derivative":{"exercise_price":0.11,"expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001694665-23-000086","document":"wk-form4_1686600340.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694665/000169466523000086/wk-form4_1686600340.xml","form_type":"4"}},{"id":1893458,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-15T22:45:46.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":3798,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3798,"derivative":{"exercise_price":99.38,"exercise_date":"2024-05-11","expiration_date":"2033-05-11","underlying":"Common Stock","underlying_shares":3798},"source":{"system":"sec-edgar","filing":"0000899243-23-013004","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000089924323013004/doc4.xml","form_type":"4"}},{"id":1893457,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-15T22:45:46.000Z","date":"2023-05-11","kind":"grant","planned":false,"acquired":true,"shares":2012,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":28482,"source":{"system":"sec-edgar","filing":"0000899243-23-013004","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000089924323013004/doc4.xml","form_type":"4"}},{"id":2108524,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-11-21T21:59:15.000Z","date":"2022-11-21","kind":"disposition_to_issuer","acquired":false,"shares":16854,"price":9.14,"value":154045.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Each stock option with a per Share exercise price that is less than the Merger Consideration was, at the Effective Time, cancelled in exchange for a cash payment equal to, for each Share underlying the stock option (without regard to vesting), the excess of the Merger Consideration over the exercise price payable per Share underlying such stock option. Any stock options with a per Share exercise price that was more than the Merger Consideration were cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each stock option with a per Share exercise price that is less than the Merger Consideration was, at the Effective Time, cancelled in exchange for a cash payment equal to, for each Share underlying the stock option (without regard to vesting), the excess of the Merger Consideration over the exercise price payable per Share underlying such stock option. Any stock options with a per Share exercise price that was more than the Merger Consideration were cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":6.11,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":16854},"source":{"system":"sec-edgar","filing":"0001209191-22-058191","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919122058191/doc4.xml","form_type":"4"}},{"id":2108523,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-11-21T21:59:15.000Z","date":"2022-11-21","kind":"disposition_to_issuer","acquired":false,"shares":7800,"price":1.98,"value":15444.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Each stock option with a per Share exercise price that is less than the Merger Consideration was, at the Effective Time, cancelled in exchange for a cash payment equal to, for each Share underlying the stock option (without regard to vesting), the excess of the Merger Consideration over the exercise price payable per Share underlying such stock option. Any stock options with a per Share exercise price that was more than the Merger Consideration were cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each stock option with a per Share exercise price that is less than the Merger Consideration was, at the Effective Time, cancelled in exchange for a cash payment equal to, for each Share underlying the stock option (without regard to vesting), the excess of the Merger Consideration over the exercise price payable per Share underlying such stock option. Any stock options with a per Share exercise price that was more than the Merger Consideration were cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":13.27,"expiration_date":"2030-06-11","underlying":"Common Stock","underlying_shares":7800},"source":{"system":"sec-edgar","filing":"0001209191-22-058191","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919122058191/doc4.xml","form_type":"4"}},{"id":2108522,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-21T21:59:15.000Z","date":"2022-11-21","kind":"disposition_to_issuer","acquired":false,"shares":16095,"price":15.25,"value":245448.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each of the reported shares of common stock of the Company (each a \"Share\" or, collectively, the \"Shares\"), including any Shares of restricted stock, was, at the Effective Time (defined below), cancelled and converted into the right to receive $15.25 in cash (the \"Merger Consideration\") without interest and subject to any applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-058191","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919122058191/doc4.xml","form_type":"4"}},{"id":2163114,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-08T20:30:33.000Z","date":"2022-09-06","kind":"sale","acquired":false,"shares":4300,"price":78.5,"value":337550.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2022."}],"balance_after":26470,"source":{"system":"sec-edgar","filing":"0000899243-22-030671","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000089924322030671/doc4.xml","form_type":"4"}},{"id":2234150,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-13T21:21:38.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":16854,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date, this option is\nscheduled to vest ratably on each of the first 12 monthly anniversaries of June 9, 2022."}],"balance_after":16854,"derivative":{"exercise_price":6.11,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":16854},"source":{"system":"sec-edgar","filing":"0001209191-22-036403","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919122036403/doc4.xml","form_type":"4"}},{"id":2234149,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-13T21:21:38.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":6245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Subject to the reporting person's continued service on the board of directors of the issuer through the vesting date, these shares of Common\nStock are scheduled to vest on June 9, 2023."}],"balance_after":16095,"source":{"system":"sec-edgar","filing":"0001209191-22-036403","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919122036403/doc4.xml","form_type":"4"}},{"id":2234198,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-13T16:48:12.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of June 9, 2023 and the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":2.6,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001694665-22-000104","document":"wf-form4_165515327929416.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694665/000169466522000104/wf-form4_165515327929416.xml","form_type":"4"}},{"id":2244691,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-06-03T20:06:25.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":21571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":139944,"source":{"system":"sec-edgar","filing":"0001209191-22-033973","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919122033973/doc4.xml","form_type":"4"}},{"id":2271987,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-13T20:31:45.000Z","date":"2022-05-11","kind":"sale","acquired":false,"shares":2980,"price":57.84,"value":172363.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2022."}],"balance_after":30770,"source":{"system":"sec-edgar","filing":"0000899243-22-018014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000089924322018014/doc4.xml","form_type":"4"}},{"id":2273497,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-12T21:47:26.000Z","date":"2022-05-06","kind":"grant","acquired":true,"shares":4068,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Form 4 originally filed on May 10, 2022 inadvertently reported 3,616 options granted on May 6, 2022 due to an administrative error. The correct amount of options granted on May 6, 2022 is 4,068 and is being reported in this amendment."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The Form 4 originally filed on May 10, 2022 inadvertently reported 3,616 options granted on May 6, 2022 due to an administrative error. The correct amount of options granted on May 6, 2022 is 4,068 and is being reported in this amendment."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Form 4 originally filed on May 10, 2022 inadvertently reported 3,616 options granted on May 6, 2022 due to an administrative error. The correct amount of options granted on May 6, 2022 is 4,068 and is being reported in this amendment."}],"balance_after":4068,"derivative":{"exercise_price":64.2,"exercise_date":"2023-05-06","expiration_date":"2032-05-06","underlying":"Common Stock","underlying_shares":4068},"source":{"system":"sec-edgar","filing":"0000899243-22-017797","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000089924322017797/doc4a.xml","form_type":"4/A","original_submission_date":"2022-05-10"}},{"id":2276130,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-10T20:40:58.000Z","date":"2022-05-06","kind":"grant","acquired":true,"shares":3616,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3616,"derivative":{"exercise_price":64.2,"exercise_date":"2023-05-06","expiration_date":"2032-05-06","underlying":"Common Stock","underlying_shares":3616},"source":{"system":"sec-edgar","filing":"0000899243-22-017445","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000089924322017445/doc4.xml","form_type":"4"}},{"id":2276129,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-10T20:40:58.000Z","date":"2022-05-06","kind":"grant","acquired":true,"shares":2180,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units cliff vest on May 6, 2023."}],"balance_after":33750,"source":{"system":"sec-edgar","filing":"0000899243-22-017445","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000089924322017445/doc4.xml","form_type":"4"}},{"id":2330712,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-03-16T20:05:33.000Z","date":"2022-03-14","kind":"sale","acquired":false,"shares":20000,"price":11.67,"value":233400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.55 to $11.77, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":118373,"source":{"system":"sec-edgar","filing":"0001209191-22-019205","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919122019205/doc4.xml","form_type":"4"}},{"id":2469811,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-16T21:06:51.000Z","date":"2021-12-14","kind":"sale","acquired":false,"shares":10000,"price":11.02,"value":110200.0,"ownership":{"direct":true},"balance_after":138373,"source":{"system":"sec-edgar","filing":"0001209191-21-069945","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919121069945/doc4.xml","form_type":"4"}},{"id":2660921,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-21T20:21:03.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":7800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date, this option is scheduled to vest ratably on each of the first 12 monthly anniversaries of June 17, 2021."}],"balance_after":7800,"derivative":{"exercise_price":16.21,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":7800},"source":{"system":"sec-edgar","filing":"0001209191-21-041989","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919121041989/doc4.xml","form_type":"4"}},{"id":2660920,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-21T20:21:03.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Subject to the reporting person's continued service on the board of directors of the issuer through the vesting date, these shares of Common Stock are scheduled to vest on June 17, 2022."}],"balance_after":9850,"source":{"system":"sec-edgar","filing":"0001209191-21-041989","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919121041989/doc4.xml","form_type":"4"}},{"id":2680893,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-06-04T20:13:10.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":22766,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":148373,"source":{"system":"sec-edgar","filing":"0001209191-21-038199","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919121038199/doc4.xml","form_type":"4"}},{"id":2716332,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-12T20:30:47.000Z","date":"2021-05-10","kind":"grant","acquired":true,"shares":8513,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":31570,"source":{"system":"sec-edgar","filing":"0000899243-21-019270","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000089924321019270/doc4.xml","form_type":"4"}},{"id":2741978,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-04-22T20:02:23.000Z","date":"2021-04-20","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted in connection with additional time the reporting person is spending providing counsel and guidance to the Company's senior leadership team during the chief executive officer transition period, vests in full on March 15, 2022."}],"balance_after":125607,"source":{"system":"sec-edgar","filing":"0001209191-21-027938","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919121027938/doc4.xml","form_type":"4"}},{"id":2750368,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-13T20:30:09.000Z","date":"2021-04-09","kind":"sale","acquired":false,"shares":2800,"price":21.22,"value":59416.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2021."}],"balance_after":23057,"source":{"system":"sec-edgar","filing":"0000899243-21-015614","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000089924321015614/doc4.xml","form_type":"4"}},{"id":2750460,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-13T16:56:42.000Z","date":"2021-04-09","kind":"grant","acquired":true,"shares":31380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 36 substantially equal monthly installments following the grant date and has a term of 10 years."}],"balance_after":31380,"derivative":{"exercise_price":10.04,"expiration_date":"2031-04-08","underlying":"Common Stock","underlying_shares":31380},"source":{"system":"sec-edgar","filing":"0001694665-21-000051","document":"wf-form4_161834738814163.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694665/000169466521000051/wf-form4_161834738814163.xml","form_type":"4"}},{"id":3013193,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-05T20:50:15.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":1259,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As previously disclosed, the Board of Directors of the Company elected to receive all remaining compensation payable in 2020 in the form of time-based restricted stock units, rather than in cash.  The transaction reported in this Form 4 reports the additional restricted stock units earned by the reporting person for the compensation payable in the fourth quarter of 2020, as calculated by the Company on October 1, 2020."}],"balance_after":25857,"source":{"system":"sec-edgar","filing":"0000899243-20-027271","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000089924320027271/doc4.xml","form_type":"4"}},{"id":3035515,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2020-09-09T22:26:27.000Z","date":"2020-09-08","kind":"sale","acquired":false,"shares":7950,"price":9.77,"value":77671.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax withholding obligations in connection with the vesting of the reporting person's director restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.53 to $9.92, inclusive.\nThe reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":123107,"source":{"system":"sec-edgar","filing":"0001209191-20-049868","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919120049868/doc4.xml","form_type":"4"}},{"id":3060196,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-12T21:36:33.000Z","date":"2020-08-10","kind":"grant","acquired":true,"shares":749,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As previously disclosed, including most recently in our Form 10-Q for the fiscal period ended June 30, 2020, the Board of Directors of the Company elected to receive all remaining compensation payable in 2020 in the form of time-based restricted stock units, rather than in cash.  The transaction reported in this Form 4 reports the additional restricted stock units earned by the reporting person for the compensation payable in the third quarter of 2020, as finally calculated by the Company on August 10, 2020."}],"balance_after":24598,"source":{"system":"sec-edgar","filing":"0000899243-20-022149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000089924320022149/doc4.xml","form_type":"4"}},{"id":3097540,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-30T00:01:04.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":7800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date, this option is scheduled to vest ratably on each of the first 12 monthly anniversaries of June 11, 2020."}],"balance_after":7800,"derivative":{"exercise_price":13.27,"expiration_date":"2030-06-11","underlying":"Common Stock","underlying_shares":7800},"source":{"system":"sec-edgar","filing":"0001209191-20-039258","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919120039258/doc4.xml","form_type":"4"}},{"id":3097539,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-30T00:01:04.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Subject to the reporting person's continued service on the board of directors of the issuer through the vesting date, these shares of Common Stock are scheduled to vest on June 11, 2021."}],"balance_after":8100,"source":{"system":"sec-edgar","filing":"0001209191-20-039258","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919120039258/doc4.xml","form_type":"4"}},{"id":3120352,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2020-06-05T20:35:31.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":21720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":131057,"source":{"system":"sec-edgar","filing":"0001209191-20-034696","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919120034696/doc4.xml","form_type":"4"}},{"id":3147233,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-15T21:24:22.000Z","date":"2020-05-13","kind":"grant","acquired":true,"shares":64103,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in full on the day immediately prior to the next annual stockholders' meeting, subject to the reporting person's continuous service through such vesting date."}],"balance_after":64103,"derivative":{"exercise_price":1.05,"expiration_date":"2030-05-13","underlying":"Common Stock","underlying_shares":64103},"source":{"system":"sec-edgar","filing":"0001209191-20-029775","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919120029775/doc4.xml","form_type":"4"}},{"id":3224513,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-05T21:30:53.000Z","date":"2020-03-03","kind":"grant","acquired":true,"shares":8095,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":23849,"source":{"system":"sec-edgar","filing":"0000899243-20-007196","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000089924320007196/doc4.xml","form_type":"4"}},{"id":3238066,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-02T21:34:01.000Z","date":"2020-02-27","kind":"sale","acquired":false,"shares":1756,"price":15.857,"value":27844.892,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $15.58 to $16.10, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., (\"LNTH\") any security holder of LNTH or the staff of the Securities and Exchange Commission (\"SEC\"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":15754,"source":{"system":"sec-edgar","filing":"0000899243-20-006494","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000089924320006494/doc4.xml","form_type":"4"}},{"id":3497140,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2019-06-07T20:05:03.000Z","date":"2019-06-05","kind":"sale","acquired":false,"shares":1500,"price":11.26,"value":16890.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax withholding obligations in connection with the vesting of the reporting person's director restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $11.15 to $11.37, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":109337,"source":{"system":"sec-edgar","filing":"0001209191-19-035509","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919119035509/doc4.xml","form_type":"4"}},{"id":3506357,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2019-05-31T20:12:19.000Z","date":"2019-05-29","kind":"grant","acquired":true,"shares":22706,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock, granted pursuant to the director compensation policy, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year."}],"balance_after":110837,"source":{"system":"sec-edgar","filing":"0001209191-19-033630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919119033630/doc4.xml","form_type":"4"}},{"id":3513417,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-23T22:16:50.000Z","date":"2019-05-23","kind":"grant","acquired":true,"shares":7800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date, this option is scheduled to vest ratably on each of the first 12 monthly anniversaries of May 23, 2019."}],"balance_after":7800,"derivative":{"exercise_price":39.44,"expiration_date":"2029-05-23","underlying":"Common Stock","underlying_shares":7800},"source":{"system":"sec-edgar","filing":"0001209191-19-032437","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919119032437/doc4.xml","form_type":"4"}},{"id":3513416,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-23T22:16:50.000Z","date":"2019-05-23","kind":"grant","acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Subject to the reporting person's continued service on the board of directors of the issuer through the vesting date, these shares of Common Stock are scheduled to vest on May 23, 2020."}],"balance_after":6350,"source":{"system":"sec-edgar","filing":"0001209191-19-032437","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919119032437/doc4.xml","form_type":"4"}},{"id":3523837,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-16T21:32:29.000Z","date":"2019-05-16","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in full on the day immediately prior to the next annual stockholders' meeting, subject to the reporting person's continuous service through such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":1.34,"expiration_date":"2029-05-16","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-19-030525","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919119030525/doc4.xml","form_type":"4"}},{"id":3604140,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-08T21:33:16.000Z","date":"2019-03-06","kind":"sale","acquired":false,"shares":2595,"price":22.765,"value":59075.175,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $22.57 to $23.01, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., (\"LNTH\") any security holder of LNTH or the staff of the Securities and Exchange Commission (\"SEC\"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":17510,"source":{"system":"sec-edgar","filing":"0000899243-19-006915","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000089924319006915/doc4.xml","form_type":"4"}},{"id":3608359,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2019-03-06T21:07:46.000Z","date":"2019-03-05","kind":"sale","acquired":false,"shares":1500,"price":14.38,"value":21570.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax withholding obligations in connection with the vesting of the reporting person's director restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.16 to $14.65, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":88131,"source":{"system":"sec-edgar","filing":"0001209191-19-017305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919119017305/doc4.xml","form_type":"4"}},{"id":3626300,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-28T21:16:38.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":5353,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20105,"source":{"system":"sec-edgar","filing":"0000899243-19-005215","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000089924319005215/doc4.xml","form_type":"4"}},{"id":3737584,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2018-12-10T21:56:04.000Z","date":"2018-12-06","kind":"sale","acquired":false,"shares":1500,"price":12.46,"value":18690.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax withholding obligations in connection with the vesting of the reporting person's director restricted stock awards."}],"balance_after":89631,"source":{"system":"sec-edgar","filing":"0001209191-18-061804","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919118061804/doc4.xml","form_type":"4"}},{"id":3821982,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2018-09-07T20:01:24.000Z","date":"2018-09-05","kind":"sale","acquired":false,"shares":1500,"price":19.1,"value":28650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax withholding obligations in connection with the vesting of the reporting person's director restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.03 to $19.26, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":91131,"source":{"system":"sec-edgar","filing":"0001209191-18-050030","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919118050030/doc4.xml","form_type":"4"}},{"id":3882242,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-27T21:06:06.000Z","date":"2018-06-25","kind":"sale","acquired":false,"shares":4560,"price":14.72,"value":67123.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 24, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $14.55 to $15.00, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc., (\"LNTH\") any security holder of LNTH or the staff of the Securities and Exchange Commission (\"SEC\"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":14752,"source":{"system":"sec-edgar","filing":"0000899243-18-018348","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000089924318018348/doc4.xml","form_type":"4"}},{"id":3899959,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-08T23:56:13.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":7800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date, this option is scheduled to vest ratably on each of the first 12 monthly anniversaries of June 7, 2018."}],"balance_after":7800,"derivative":{"exercise_price":65.15,"expiration_date":"2028-06-07","underlying":"Common Stock","underlying_shares":7800},"source":{"system":"sec-edgar","filing":"0001209191-18-036807","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919118036807/doc4.xml","form_type":"4"}},{"id":3899958,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-08T23:56:13.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Subject to the reporting person's continued service on the board of directors of the issuer through the vesting date, these shares of Common Stock are scheduled to vest on June 7, 2019."}],"balance_after":4600,"source":{"system":"sec-edgar","filing":"0001209191-18-036807","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919118036807/doc4.xml","form_type":"4"}},{"id":3901595,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2018-06-07T20:23:40.000Z","date":"2018-06-05","kind":"sale","acquired":false,"shares":1500,"price":17.62,"value":26430.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax withholding obligations in connection with the vesting of the reporting person's director restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.41 to $17.87, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":92631,"source":{"system":"sec-edgar","filing":"0001209191-18-036346","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919118036346/doc4.xml","form_type":"4"}},{"id":3908325,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2018-06-04T21:29:05.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":16223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Director Compensation Plan, effective as of January 2014."}],"balance_after":94131,"source":{"system":"sec-edgar","filing":"0001209191-18-035248","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919118035248/doc4.xml","form_type":"4"}},{"id":3928123,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-17T21:07:42.000Z","date":"2018-05-16","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in full on the day immediately prior to the next annual stockholders' meeting, subject to the reporting person's continuous service through such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":1.84,"expiration_date":"2028-05-16","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-18-031027","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919118031027/doc4.xml","form_type":"4"}},{"id":4008243,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-07T21:43:02.000Z","date":"2018-03-05","kind":"grant","acquired":true,"shares":7911,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19312,"source":{"system":"sec-edgar","filing":"0000899243-18-006657","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000089924318006657/doc4.xml","form_type":"4"}},{"id":4010929,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2018-03-07T00:15:09.000Z","date":"2018-03-05","kind":"sale","acquired":false,"shares":1500,"price":14.06,"value":21090.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax withholding obligations in connection with the vesting of the reporting person's director restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.10, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":77908,"source":{"system":"sec-edgar","filing":"0001209191-18-017509","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919118017509/doc4.xml","form_type":"4"}},{"id":4140379,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2017-12-06T21:12:59.000Z","date":"2017-12-04","kind":"sale","acquired":false,"shares":1500,"price":16.45,"value":24675.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax withholding obligations in connection with the vesting of the reporting person's director restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.18 to $17.03, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":79408,"source":{"system":"sec-edgar","filing":"0001209191-17-064178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919117064178/doc4.xml","form_type":"4"}},{"id":4214700,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2017-09-07T20:38:35.000Z","date":"2017-09-05","kind":"sale","acquired":false,"shares":1500,"price":16.16,"value":24240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and was effected to cover tax withholding obligations in connection with the vesting of the reporting person's director restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.08 to $16.32, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":80908,"source":{"system":"sec-edgar","filing":"0001209191-17-051887","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919117051887/doc4.xml","form_type":"4"}},{"id":4286988,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-09T20:06:01.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date, this option is scheduled to vest ratably on each of the first 12 monthly anniversaries of June 8, 2017."}],"balance_after":10000,"derivative":{"exercise_price":52.85,"expiration_date":"2027-06-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-038854","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919117038854/doc4.xml","form_type":"4"}},{"id":4286987,"issuer":{"id":122210,"kind":"organization","name":"AERIE PHARMACEUTICALS INC","symbol":"AERI"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-09T20:06:01.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":1150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Subject to the reporting person's continued service on the board of directors of the issuer through the vesting date, these shares of Common Stock are scheduled to vest on June 8, 2018."}],"balance_after":2850,"source":{"system":"sec-edgar","filing":"0001209191-17-038854","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919117038854/doc4.xml","form_type":"4"}},{"id":4291057,"issuer":{"id":85383,"kind":"organization","name":"TREVENA INC","symbol":"TRVN"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-06T20:43:32.000Z","date":"2017-05-17","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in full on the day immediately prior to the next annual stockholders' meeting, subject to the reporting person's continuous service through such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":3.08,"expiration_date":"2027-05-17","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-17-038139","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919117038139/doc4.xml","form_type":"4"}},{"id":4295776,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2017-06-02T21:02:09.000Z","date":"2017-05-31","kind":"grant","acquired":true,"shares":15625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Issued pursuant to the Director Compensation Plan, effective as of January 2014."}],"balance_after":82408,"source":{"system":"sec-edgar","filing":"0001209191-17-037353","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000120919117037353/doc4.xml","form_type":"4"}},{"id":4414031,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-01T21:07:23.000Z","date":"2017-02-27","kind":"grant","acquired":true,"shares":8730,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11401,"source":{"system":"sec-edgar","filing":"0000899243-17-005788","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000089924317005788/doc4.xml","form_type":"4"}},{"id":4480579,"issuer":{"id":690,"kind":"organization","name":"Lantheus Holdings, Inc.","symbol":"LNTH"},"owners":[{"id":37247,"kind":"person","name":"McHugh Julie","position":1,"cik":"0001487179","reported_name":"McHugh Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-26T23:10:45.000Z","date":"2017-01-25","kind":"grant","acquired":true,"shares":2671,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2671,"source":{"system":"sec-edgar","filing":"0001593968-17-000163","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487179/000159396817000163/primary_01.xml","form_type":"4"}}]}